Q3 2017 Holdings
Filed 2017-11-14 | 159 holdings | $6.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Oneok Inc NewCall | CALL | 682680903 | $1 | 201 | 0.0% |
| Energy Transfer Partners LPCall | CALL | 29278N903 | $1 | 100 | 0.0% |
| Enterprise Prods Partners LCall | CALL | 293792907 | $2 | 300 | 0.0% |
| Plains All Amern Pipeline LCall | CALL | 726503905 | $2 | 450 | 0.0% |
| Marathon Pete CorpCall | CALL | 56585A902 | $3 | 2,885 | 0.0% |
| Williams COS Inc delPut | PUT | 969457950 | $4 | 800 | 0.0% |
| United States Natl Gas FundPut | PUT | 912318951 | $4 | 744 | 0.0% |
| Ishares TRPut | PUT | 464287952 | $7 | 1,400 | 0.0% |
| Marathon Pete CorpPut | PUT | 56585A952 | $9 | 1,607 | 0.0% |
| Kinder Morgan Inc delCall | CALL | 49456B901 | $16 | 4,000 | 0.0% |
| Oneok Inc NewPut | PUT | 682680953 | $20 | 2,000 | 0.0% |
| Ishares TRCall | CALL | 464287902 | $25 | 12,432 | 0.0% |
| Energy Transfer Equity L PPut | PUT | 29273V950 | $32 | 7,942 | 0.0% |
| JPMorgan Chase & CoCall | CALL | 46625H905 | $45 | 9,000 | 0.0% |
| Versartis Inc | COM | 92529L102 | $49 | 19,991 | 0.0% |
| United States Natl Gas FundCall | CALL | 912318901 | $82 | 41,012 | 0.0% |
| Axovant Sciences LTD | COM | G0750W104 | $97 | 14,151 | 0.0% |
| Dominion Midstream Partners | COM UT REP LTD | 257454108 | $102 | 3,189 | 0.0% |
| Spdr S&P 500 ETF TRCall | CALL | 78462F903 | $111 | 1,800 | 0.0% |
| United States Oil Fund LPCall | CALL | 91232N908 | $175 | 87,212 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $239 | 19,472 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $259 | 18,915 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $260 | 34,183 | 0.0% |
| Inovio Pharmaceuticals Inc | COM NEW | 45773H201 | $261 | 41,233 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $264 | 4,234 | 0.0% |
| Geron Corp(GERN) | COM | 374163103 | $273 | 125,425 | 0.0% |
| Proshares TR(UPW) | PSHS ULTRA UTIL | 74347R685 | $277 | 5,800 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $285 | 5,343 | 0.0% |
| Tetraphase Pharmaceuticals I | COM | 88165N105 | $308 | 45,001 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $316 | 20,298 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $321 | 126,385 | 0.0% |
| Aduro Biotech Inc(ADROEUR) | COM | 00739L101 | $327 | 30,685 | 0.0% |
| Aquinox Pharmaceuticals Inc | COM | 03842B101 | $339 | 23,869 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $341 | 18,449 | 0.0% |
| Achillion Pharmaceuticals in(ACHNEUR) | COM | 00448Q201 | $348 | 77,433 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $349 | 29,453 | 0.0% |
| Novavax Inc | COM | 670002104 | $351 | 308,286 | 0.0% |
| Ziopharm Oncology Inc | COM | 98973P101 | $362 | 59,009 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $364 | 15,881 | 0.0% |
| Calithera Biosciences Inc(CALAEUR) | COM | 13089P101 | $367 | 23,312 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $368 | 11,845 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $370 | 14,726 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $392 | 6,048 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $392 | 19,612 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $393 | 35,776 | 0.0% |
| Corbus Pharmaceuticals Hldgs(CRBPEUR) | COM | 21833P103 | $400 | 55,909 | 0.0% |
| Celldex Therapeutics Inc New | COM | 15117B103 | $400 | 139,774 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $402 | 12,925 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $404 | 2,945 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $405 | 28,961 | 0.0% |